Lawmakers contend WHO pain treatment guidelines are really Purdue ‘marketing materials’ – By ED SILVERMAN @Pharmalot MAY 22, 2019 – (article at “https://www.statnews.com/pharmalot/2019/05/22/purdue-opioids-world-health-guidelines/” accessible only through subscription to StatPlus)
Just the two first paragraphs of visible preview are astonishing and so infuriating that I’ll just leave you with these two:
Two lawmakers are urging the World Health Organization to rescind guidelines issued nearly a decade ago for treating pain because they contain “dangerously misleading” and sometimes “outright false claims” about the safety and effectiveness that were orchestrated by Purdue Pharma.
In a new report, the lawmakers contend that the WHO guidelines, which were released in 2011 and 2012, are “serving as marketing materials for Purdue.” And they pointed to efforts by the company to create and fund front groups that participated in research that shaped WHO decision making – and dovetailed with corporate goals to boost use of opioids, such as its own OxyContin pill.
FDA identifies sudden discontinuation of opioid pain medicines – fda.gov – Apr 2019
I don’t know how I missed this until now. If your doctor is trying to force you into a taper, you can let them know that the FDA warns against taking opioids away from pain patients without a medical reason and then only in a carefully planned extremely gradual taper.
The U.S. Food and Drug Administration (FDA) has received reports of serious harm in patients who are physically dependent on opioid pain medicines suddenly having these medicines discontinued or the dose rapidly decreased.
These include serious withdrawal symptoms, uncontrolled pain, psychological distress, and suicide. Continue reading
Limits on Opioid Prescribing Leave Patients With Chronic Pain Vulnerable – from Jama – Rita Rubin, MA – April 29, 2019
Thomas Kline, MD, PhD, refers to 22 of his patients as “pain refugees.”
Stable for years taking opioid therapy for chronic pain, these patients sought out Kline—well-known for his advocacy on their behalf on Twitter and elsewhere—because their physicians had abruptly cut their dose or refused to refill a prescription.
They had appealed to multiple physicians for treatment with no success before contacting him, said Kline. Continue reading
Seeking to Clarify Its Opioid Prescribing Guidelines, CDC Joins FDA in Decrying ‘Mandated or Abrupt Dose Reduction’– by Jacob Sullum – Apr 2019
Acknowledging the suffering caused by “misinterpretation” of the opioid prescribing guidelines it published in 2016, the U.S. Centers for Disease Control and Prevention (CDC) yesterday sought to clarify that it never recommended imposing involuntary dose reductions on chronic pain patients.
In a letter to physicians who had objected to that widespread practice, CDC Director Robert Redfield emphasized that his agency “does not endorse mandated or abrupt dose reduction or discontinuation, as these actions can result in patient harm.”
The CDC may not “endorse” them, but they deliberately looked the other way for 3 years while this was happening. Continue reading
CDC Guideline Harms Pain Patients, Panel Says – by Judy George, Contributing Writer, MedPage Today – March 11, 2019
The CDC’s 2016 opioid guideline is being implemented in ways that harm chronic pain patients, a panel of physicians said here.
I agree that the problem isn’t with the guidelines themselves. They were just
2) for primary care providers and
3) first-time opioid prescriptions.
The problem is that they have been weaponized by anti-opioid crusaders to make laws and rules that force opioid tapers even when not medically indicated. Continue reading
Could CDC Guidelines Be Driving Some Opioid Patients to Suicide? – Rolling Stone – by EJ Dickson – Mar 2019
Some doctors have issues with the suggestions made by the CDC for how opioids should be prescribed for pain.
Since the Centers for Disease Control issued its guidelines dictating appropriate opioid prescription rates and dosages in 2016, opioid prescriptions have declined significantly. Overdose deaths have also been on the decline, though some health experts believe that effect might be temporary.
Two groups that have not benefited from increasing public health efforts to stem the opioid crisis, however, is people living with chronic pain and their health care providers. Continue reading
CDC Opioid Prescribing Guideline: Unintended Consequences? – July 2018 – an angry essay by yours truly, Angelika Byczkowski (Zyp Czyk)
I’m sick and tired of reading over and over how all the entirely predictable consequences of the CDC Opioid Prescribing Guideline were “unintended” and “unforeseeable”.
The broad misinterpretation of the guideline as establishing fixed limits on opioid prescribing has stranded hundreds of thousands of pain patients in agony without the effective relief they had achieved with opioids.
Yet we are expected to believe that these consequences were “unintended” and “unforeseeable” by the guideline authors. Most pain patients realized right away that the guideline’s suggestions would become codified rules, no matter how little evidence supported them.
And we were right – more than we ever imagined… Continue reading
Medical guidelines may be biased, overly aggressive in US – Cornell University – Apr 2019
Dr. Sunita Sah practiced general medicine for several years in the United Kingdom’s National Health Service. When she came to the United States, she noticed something strange.
The U.K. guidelines for tests such as mammograms and colon cancer screenings drastically differed from those in the U.S…
…even though they were based on the same medical evidence. Continue reading
SUPPORTERS’ SIGNATURES and COMMENTS – Sep 2018
Health Professionals Call on the CDC to Address Misapplication of its Guideline on Opioids for Chronic Pain through Public Clarification and Impact Evaluation
Individuals wishing to register their solidarity with this effort, who are not health professionals, should sign on this page.
This document has 129 pages of signatories and their comments. I tried to clean it up a little, but I had to stop part way because it’s just too long. I’ve posted it here just in case the original Google Doc disappears.
You may enjoy, like I did, finding out how many medical professionals are protesting and how many pain patients are scattered all across America suffering from their individual burdens of pain. Continue reading
Too Little, Too Late: US Government Backtracks on Opioid Discontinuation
Thousands of patients have been dispassionately forced into tapering their opioids, often inappropriately, due to fear from regulatory agencies following initiation of the 2016 CDC Guideline on Prescribing Opioids for Chronic Pain.
In addition to unnecessary suffering, this has resulted in opioid withdrawal due to due either rapid or misguided or inexperienced taper regimens.
The sad irony here is that three years later, the FDA is saying exactly what nationally recognized pain experts have been saying all along. Continue reading